{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:05:42Z","timestamp":1791353142605,"version":"4.3.1"},"reference-count":62,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.semcancer.2011.09.006","type":"journal-article","created":{"date-parts":[[2011,9,18]],"date-time":"2011-09-18T21:25:20Z","timestamp":1316381120000},"page":"308-312","source":"Crossref","is-referenced-by-count":53,"title":["The microenvironment in mantle cell lymphoma: Cellular and molecular pathways and emerging targeted therapies"],"prefix":"10.1016","volume":"21","author":[{"given":"Jan A.","family":"Burger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semcancer.2011.09.006_bib0005","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1182\/blood-2010-04-189977","article-title":"Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era","volume":"117","author":"Perez-Galan","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0010","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1182\/blood-2009-06-225326","article-title":"The microenvironment in mature B-cell malignancies: a target for new treatment strategies","volume":"114","author":"Burger","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0015","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s13402-011-0019-7","article-title":"Phospho-proteomic analysis of mantle cell lymphoma cells suggests a pro-survival role of B-cell receptor signaling","volume":"34","author":"Pighi","year":"2011","journal-title":"Cellular Oncology (Dordrecht)"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0020","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/sj.leu.2401664","article-title":"Proliferative response of mantle cell lymphoma cells stimulated by CD40 ligation and IL-4","volume":"14","author":"Castillo","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0025","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1182\/blood.V96.6.2219","article-title":"Soluble CD40 ligand induces selective proliferation of lymphoma cells in primary mantle cell lymphoma cell cultures","volume":"96","author":"Andersen","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0030","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1182\/blood-2008-10-185827","article-title":"Mantle cell lymphoma cells express high levels of CXCR4, CXCR5, and VLA-4 (CD49d): importance for interactions with the stromal microenvironment and specific targeting","volume":"113","author":"Kurtova","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0035","doi-asserted-by":"crossref","first-page":"5142","DOI":"10.1182\/blood-2007-07-103481","article-title":"Distinct functional significance of Akt and mTOR constitutive activation in mantle cell lymphoma","volume":"111","author":"Dal Col","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0040","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.humpath.2005.08.005","article-title":"BAFF-R, the major B cell-activating factor receptor, is expressed on most mature B cells and B-cell lymphoproliferative disorders","volume":"36","author":"Rodig","year":"2005","journal-title":"Human Pathology"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0045","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00428-005-1275-6","article-title":"Expression of BAFF-R (BR 3) in normal and neoplastic lymphoid tissues characterized with a newly developed monoclonal antibody","volume":"447","author":"Nakamura","year":"2005","journal-title":"Virchows Archive"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0050","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4049\/jimmunol.171.1.88","article-title":"Inhibition of constitutive NF-kappa B activation in mantle cell lymphoma B cells leads to induction of cell cycle arrest and apoptosis","volume":"171","author":"Pham","year":"2003","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0055","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4161\/cc.10.2.14570","article-title":"The role of BAFF-R dysregulation in B-lymphoid lineage malignancies","volume":"10","author":"Pham","year":"2011","journal-title":"Cell Cycle (Georgetown, Tex.)"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0060","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1182\/blood-2003-09-3103","article-title":"Homeostatic chemokines drive migration of malignant B cells in patients with non-Hodgkin lymphomas","volume":"104","author":"Trentin","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0065","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1182\/blood.V94.11.3658","article-title":"Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells","volume":"94","author":"Burger","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0070","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1182\/blood-2007-05-089409","article-title":"Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia","volume":"110","author":"Burkle","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0075","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/nature03703","article-title":"In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment","volume":"435","author":"Sipkins","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0080","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1182\/blood.V93.5.1658","article-title":"Cell adhesion mediated drug resistance (CAM-DR): role of integrins and resistance to apoptosis in human myeloma cell lines","volume":"93","author":"Damiano","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0085","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa041869","article-title":"Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells","volume":"351","author":"Dave","year":"2004","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0090","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1182\/blood-2005-04-1565","article-title":"Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL)","volume":"106","author":"Farinha","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0095","doi-asserted-by":"crossref","first-page":"4764","DOI":"10.1182\/blood-2007-10-115915","article-title":"Clinical quantitation of immune signature in follicular lymphoma by RT-PCR-based gene expression profiling","volume":"111","author":"Byers","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0100","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1182\/blood-2008-07-170415","article-title":"High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation","volume":"113","author":"Burger","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0105","article-title":"The lymph node microenvironment promotes B-cell receptor signaling, NF-{kappa}B activation, and tumor proliferation in chronic lymphocytic leukemia","author":"Herishanu","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0110","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1535-6108(03)00028-X","article-title":"The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma","volume":"3","author":"Rosenwald","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0115","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1182\/blood-2005-04-1753","article-title":"Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling","volume":"106","author":"Fu","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0120","first-page":"8226","article-title":"The molecular signature of mantle cell lymphoma reveals multiple signals favoring cell survival","volume":"63","author":"Martinez","year":"2003","journal-title":"Cancer Research"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0125","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1365-2141.2005.05630.x","article-title":"Gene expression profiling of mantle cell lymphoma cells reveals aberrant expression of genes from the PI3K-AKT, WNT and TGFbeta signalling pathways","volume":"130","author":"Rizzatti","year":"2005","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0130","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2141.2005.05883.x","article-title":"Genomic and expression profiling identifies the B-cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma","volume":"132","author":"Rinaldi","year":"2006","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0135","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.1002\/pmic.200800080","article-title":"Signal transduction pathways of mantle cell lymphoma: a phosphoproteome-based study","volume":"8","author":"Cecconi","year":"2008","journal-title":"Proteomics"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0140","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1182\/blood-2005-08-3376","article-title":"Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma","volume":"107","author":"Yang","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0145","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1046\/j.1365-2141.1998.00684.x","article-title":"Bone marrow and peripheral blood involvement in mantle cell lymphoma","volume":"101","author":"Cohen","year":"1998","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0150","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1182\/blood.V89.6.2067","article-title":"Mantle cell lymphoma: a clinicopathologic study of 80 cases","volume":"89","author":"Argatoff","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0155","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2559.1995.tb00615.x","article-title":"Mantle cell lymphoma: a clinicopathological study of 55 cases","volume":"26","author":"Pittaluga","year":"1995","journal-title":"Histopathology"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0160","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1200\/JCO.2006.06.1648","article-title":"Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma","volume":"25","author":"Glas","year":"2007","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0165","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1182\/blood.V96.8.2655","article-title":"Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1","volume":"96","author":"Burger","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0170","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1182\/blood.V99.3.1030","article-title":"Distinctive features of nurselike cells that differentiate in the context of chronic lymphocytic leukemia","volume":"99","author":"Tsukada","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0175","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2004-12-4918","article-title":"Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells","author":"Burger","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0180","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/283402a0","article-title":"Thymic nurse cells \u2013 Ia-bearing epithelium involved in T-lymphocyte differentiation?","volume":"283","author":"Wekerle","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0185","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.cell.2006.01.007","article-title":"Macrophages: obligate partners for tumor cell migration, invasion, and metastasis","volume":"124","author":"Condeelis","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0190","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1034\/j.1600-065X.2000.00618.x","article-title":"Follicular stromal cells and lymphocyte homing to follicles","volume":"176","author":"Cyster","year":"2000","journal-title":"Immunology Review"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0195","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature06287","article-title":"Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells","volume":"450","author":"Junt","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0200","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.immuni.2007.06.007","article-title":"B cells acquire particulate antigen in a macrophage-rich area at the boundary between the follicle and the subcapsular sinus of the lymph node","volume":"27","author":"Carrasco","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0205","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/ni.1946","article-title":"B cell follicles and antigen encounters of the third kind","volume":"11","author":"Cyster","year":"2010","journal-title":"Nature Immunology"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0210","doi-asserted-by":"crossref","first-page":"5228","DOI":"10.1182\/blood-2010-03-275925","article-title":"Follicular dendritic cell-dependent drug resistance of non-Hodgkin lymphoma involves cell adhesion-mediated Bim down-regulation through induction of microRNA-181a","volume":"116","author":"Lwin","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0215","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1182\/blood-2006-11-060350","article-title":"Cell adhesion induces p27Kip1-associated cell-cycle arrest through down-regulation of the SCFSkp2 ubiquitin ligase pathway in mantle-cell and other non-Hodgkin B-cell lymphomas","volume":"110","author":"Lwin","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0220","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/sj.leu.2402107","article-title":"Differential expression of chemokine receptors in B cell malignancies","volume":"15","author":"Durig","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0225","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1158\/1078-0432.CCR-1182-3","article-title":"CCL19 and CXCL12 trigger in vitro chemotaxis of human mantle cell lymphoma B cells","volume":"10","author":"Corcione","year":"2004","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0230","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1200\/JCO.1999.17.6.1869","article-title":"Expression of beta-integrin adhesion molecules in non-Hodgkin\u2018s lymphoma: correlation with clinical and evolutive features","volume":"17","author":"Terol","year":"1999","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0235","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.immuni.2007.07.009","article-title":"Germinal-center organization and cellular dynamics","volume":"27","author":"Allen","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0240","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0092-8674(94)90337-9","article-title":"Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm","volume":"76","author":"Springer","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0245","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/leu.2008.299","article-title":"CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers","volume":"23","author":"Burger","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0250","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1182\/blood.V95.6.1900","article-title":"Cell adhesion receptors in lymphoma dissemination","volume":"95","author":"Drillenburg","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0255","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0046-8177(98)90426-9","article-title":"Expression of CD44 (HCAM) in small lymphocytic and mantle cell lymphoma","volume":"29","author":"Aguilera","year":"1998","journal-title":"Human Pathology"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0260","first-page":"919","article-title":"Preferential expression of the mucosal homing receptor integrin alpha 4 beta 7 in gastrointestinal non-Hodgkin's lymphomas","volume":"150","author":"Drillenburg","year":"1997","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0265","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/S0002-9440(10)65684-2","article-title":"Homing receptor alpha4beta7 integrin expression predicts digestive tract involvement in mantle cell lymphoma","volume":"153","author":"Geissmann","year":"1998","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0270","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0092-8674(93)90305-A","article-title":"Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1","volume":"74","author":"Berlin","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0275","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1056\/NEJMra041720","article-title":"Chronic lymphocytic leukemia","volume":"352","author":"Chiorazzi","year":"2005","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0280","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1182\/blood-2009-08-236471","article-title":"Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia","volume":"115","author":"Friedberg","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0285","doi-asserted-by":"crossref","first-page":"13075","DOI":"10.1073\/pnas.1004594107","article-title":"The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy","volume":"107","author":"Honigberg","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0290","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1182\/blood-2010-03-275305","article-title":"CAL-101, a p110delta selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability","volume":"117","author":"Lannutti","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0295","doi-asserted-by":"crossref","first-page":"32a","DOI":"10.1182\/blood.V116.21.57.57","article-title":"The Bruton\u2018s tyrosine kinase inhibitor, PCI-32765, is well tolerated and demonstrates promising clinical activity in chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL): an update on ongoing phase 1 studies","volume":"116","author":"Burger","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0300","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1182\/blood.V116.21.964.964","article-title":"The Btk inhibitor, PCI-32765, induces durable responses with minimal toxicity in patients with relapsed\/refractory B-cell malignancies: results from a phase I study","volume":"116","author":"Fowler","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0305","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V114.22.922.922","article-title":"Evidence of clinical activity in a phase 1 study of CAL-101, an oral P110 isoform-selective inhibitor of phosphatidylinositol 3-kinase, in patients with relapsed or refractory B-cell malignancies","volume":"114","author":"Flinn","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2011.09.006_bib0310","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1182\/blood-2006-04-015586","article-title":"Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma","volume":"108","author":"Rudelius","year":"2006","journal-title":"Blood"}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X11000551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X11000551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T05:17:57Z","timestamp":1592975877000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X11000551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":62,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S1044579X11000551"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2011.09.006","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}